Hybrid PET/MRI in neuro-imaging;TEP/IRM hybride en neuro-imagerie

Medecine Nucleaire

Volumn 37, Issue 10-11, 2013, Pages 561-566

  Garibotto, V ^a   Tabouret Viaud, C ^a   Rager, O ^a   Vulliemoz, S ^a   Delattre, B ^b   Haller, S ^a   Wissmeyer, M ^a   Seeck, M ^a   Lovblad, K O ^a   Zaidi, H ^a   Gold, G ^a   Ratib, O ^a   Zekry, D ^a   Vargas, M I ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Dementias; Epilepsy; Neuro imaging; Neurodegenerative disorders; Oncology; PET MRI

Indexed keywords

FLUORINE 18; GLUCOSE;

BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSION TENSOR IMAGING; EPILEPSY; GLUCOSE BRAIN LEVEL; MEDICAL RESEARCH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RADIODIAGNOSIS; SHORT SURVEY; SWITZERLAND; TRACTOGRAPHY;

EID: 84888058923     PISSN: 09281258     EISSN: 18786820     Source Type: Journal    
DOI: 10.1016/j.mednuc.2013.09.007     Document Type: Short Survey

References (36)

1. Ratib O., Beyer T. Whole-body hybrid PET/MRI: ready for clinical use?. Eur J Nucl Med Mol Imaging 2011, 38:992-995.
2. Garibotto V., Forster S., Haller S., Vargas M.I., Drzezga A. Molecular Neuro-imaging with PET/MRI. Clin Transl Imaging 2013, 1:53-63.
3. Catana C., Drzezga A., Heiss W.D., Rosen B.R. PET/MRI for Neurologic Applications. J Nucl Med 2012, 53:1916-1925.
4. Schlemmer H.P., Pichler B.J., Schmand M., Burbar Z., Michel C., Ladebeck R., et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 2008, 248:1028-1035.
5. Zaidi H., Ojha N., Morich M., Griesmer J., Hu Z., Maniawski P., et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 2011, 56:3091-3106.
6. Ratib O., Lord M., Becker M., Viallon M., Vallée J.P., Loubeyre P., et al. Clinical applications of hybrid PET-MR. Med Nucl 2012, 36:605-614.
7. Delso G., Furst S., Jakoby B., Ladebeck R., Ganter C., Nekolla S.G., et al. Performance measurements of the siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011, 52:1914-1922.
8. Kalemis A., Delattre B.M., Heinzer S. Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective. MAGMA 2013, 26:5-23.
9. Wissmeyer M., Heinzer S., Majno P., Buchegger F., Zaidi H., Garibotto V., et al. Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging 2011, 38:1744-1745.
10. 18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer. Eur J Nucl Med Mol Imaging 2011, 38:2288.
11. Platzek I., Beuthien-Baumann B., Langner J., Popp M., Schramm G., Ordemann R., et al. PET/MR for therapy response evaluation in malignant lymphoma: initial experience. MAGMA 2013, 26:49-55.
12. Martinez-Moller A., Eiber M., Nekolla S.G., Souvatzoglou M., Drzezga A., Ziegler S., et al. Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncology. J Nucl Med 2012, 53:1415-1426.
13. Vargas M.I., Becker M., Garibotto V., Heinzer S., Loubeyre P., Gariani J., et al. Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies. MAGMA 2013, 26:57-69.
14. Chonde D.B., Abolmaali N., Arabasz G., Guimaraes A.R., Catana C. Effect of MRI acoustic noise on cerebral fludeoxyglucose uptake in simultaneous MR-PET imaging. Invest Radiol 2013, 48:302-312.
15. Dunet V., Rossier C., Buck A., Stupp R., Prior J.O. Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and meta-analysis. J Nucl Med 2012, 53:207-214.
16. Herholz K., Langen K.J., Schiepers C., Mountz J.M. Brain tumors. Semin Nucl Med 2012, 42:356-370.
17. Garibotto V., Heinzer S., Vulliemoz S., Guignard R., Wissmeyer M., Seeck M., et al. Clinical applications of hybrid PET/MRI in neuro-imaging. Clin Nucl Med 2013, 38:e13-e18.
18. Herzog H., Langen K.J., Weirich C., Rota Kops E., Kaffanke J., Tellmann L., et al. High resolution BrainPET combined with simultaneous MRI. Nuklearmedizin 2011, 50:74-82.
19. Neuner I., Kaffanke J.B., Langen K.J., Kops E.R., Tellmann L., Stoffels G., et al. Multimodal imaging utilising integrated MR-PET for human brain tumour assessment. Eur Radiol 2012, 22:2568-2580.
20. Boss A., Bisdas S., Kolb A., Hofmann M., Ernemann U., Claussen C.D., et al. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT. J Nucl Med 2010, 51:1198-1205.
21. Schwenzer N.F., Stegger L., Bisdas S., Schraml C., Kolb A., Boss A., et al. Simultaneous PET/MR imaging in a human brain PET/MR system in 50patients-current state of image quality. Eur J Radiol 2012, 81:3472-3478.
22. Bisdas S., Ritz R., Bender B., Braun C., Pfannenberg C., Reimold M., et al. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol 2013, 48:295-301.
23. Thorwarth D., Henke G., Muller A.C., Reimold M., Beyer T., Boss A., et al. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience. Int J Radiat Oncol Biol Phys 2011, 81:277-283.
24. Drzezga A. Diagnosis of Alzheimer's disease with [18F]PET in mild and asymptomatic stages. Behav Neurol 2009, 21:101-115.
25. Garibotto V., Haller S., Zekry D., Heinzer S., Lovblad K.O., Zaidi H., et al. 12th international Stockholm/Springfield symposium on advances in Alzheimer therapy; Stockholm 2012.
26. Vercher-Conejero J.L., Rubbert C., Kohan A.A., Partovi S., O'Donnell J.K. Amyloid PET/MRI in the differential diagnosis of dementia. Clin Nucl Med 2013.
27. Kumar A., Semah F., Chugani H.T., Theodore W.H. Epilepsy diagnosis: positron emission tomography. Handb Clin Neurol 2012, 107:409-424.
28. Salamon N., Kung J., Shaw S.J., Koo J., Koh S., Wu J.Y., et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology 2008, 71:1594-1601.
29. Chassoux F., Rodrigo S., Semah F., Beuvon F., Landre E., Devaux B., et al. FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 2010, 75:2168-2175.
30. Shah N.J., Oros-Peusquens A.M., Arrubla J., Zhang K., Warbrick T., Mauler J., et al. Advances in multimodal neuro-imaging: hybrid MR-PET and MR-PET-EEG at 3T and 9.4T. J Magn Reson 2013, 229:101-115.
31. Grouiller F., Heinzer S., Delattre B., Lazeyras F., Seeck M., Ratib O., et al. International conference on basic ans clinical multimodal imaging; Geneva 2013.
32. Vargas M.I., Garibotto V., Viallon M., Guignard R., Cuvinciuc V., Lovblad K., et al. Peripheral nerves, tumors, and hybrid PET-MRI. Clin Nucl Med 2013, 38:e40-e42.
33. Herzog H., Zhang K., Mauler J., Filss C., Rota Kops E., Tellmann L., et al. BrainPET; Shanghai, China: International society for cerebral blood flow and metabolism 2013.
34. Bronstein Y., Tummala S., Rohren E. F-18FDG PET/CT for detection of malignant involvement of peripheral nerves: case series and literature review. Clin Nucl Med 2011, 36:96-100.
35. Pirotte B.J., Lubansu A., Massager N., Wikler D., Van Bogaert P., Levivier M., et al. Clinical impact of integrating positron emission tomography during surgery in 85children with brain tumors. J Neurosurg Pediatr 2010, 5:486-499.
36. Larsson A., Johansson A., Axelsson J., Nyholm T., Asklund T., Riklund K., et al. Evaluation of an attenuation correction method for PET/MR imaging of the head based on substitute CT images. MAGMA 2013, 26:127-136.